Every Intervention Starts With the Same Question
Before recommending a hormone, a peptide, or a metabolic therapy, the question I ask is what it actually changes at the cellular level, not just what it changes on a lab report. This page explains that framework and where it came from.
Cellular Medicine Is a Clinical Framework, Not a Product Category
Cellular medicine describes a way of thinking about physiology, not a type of treatment. I trained in this framework through the SSRP Institute under William Seeds, MD, whose work defines cellular medicine as the study of how signals such as hormones, peptides, neurotransmitters, and growth factors change cellular metabolism, mitochondrial function, and gene expression, and how those changes eventually surface as something a patient feels or a clinician can measure. I trained separately in advanced bioidentical hormone therapy through WorldLink Medical under Neal Rouzier, MD. Both trainings converge on the same idea from different directions: hormones are not isolated interventions, they are signals that operate inside this same cellular system. Everything below is built on that foundation, credited to the physicians who developed it, not presented as something original to this practice.
From Signal to Symptom
A hormone or a peptide is a signal. What happens after that signal is received is a chain of cellular events, and most of what patients care about, energy, body composition, cognition, recovery, is the downstream output of that chain, not the signal itself. The framework below traces that chain from the molecular level to the clinical level, presented in order for readability. In practice it is not strictly one-directional, several of these levels, particularly metabolism and mitochondrial function, feed back into each other rather than moving in a single straight line.
The input layer. Hormones acting through nuclear receptors (androgen receptor, estrogen receptor, thyroid hormone receptor) or membrane receptors (GLP-1 receptor, ghrelin/GHS-R1a receptor for growth hormone secretagogue peptides), along with neurotransmitters, cytokines, and growth factors. This is where testosterone, estradiol, thyroid hormone, and peptides like CJC-1295, Ipamorelin, and Sermorelin do their work, they are signals initiating everything downstream.
How the cell handles fuel once a signal arrives. Glucose uptake and utilization, fatty acid oxidation, amino acid metabolism, and metabolic flexibility, the capacity to shift between fuel sources depending on demand. Insulin signaling sits here too, and it is frequently disrupted well before it shows up as an abnormal fasting glucose.
ATP production through oxidative phosphorylation, the NAD+/NADH redox couple that mitochondria depend on as a cofactor, and mitochondrial biogenesis, the process of building new mitochondria in response to demand. This is the layer where fatigue and low exercise capacity often actually originate, even when standard labs look normal.
Reactive oxygen species are not simply damaging, in controlled amounts they function as signaling molecules, a concept known as hormesis. Antioxidant systems (glutathione, superoxide dismutase, catalase) buffer this. Oxidative stress is what happens when ROS production outpaces the buffering capacity, and it is a mechanistic link between metabolic dysfunction and the inflammation and tissue damage that follow.
Chronic, low-grade inflammation, sometimes called inflammaging, is closely tied to metabolic and mitochondrial dysfunction upstream and is a recognized driver of many of the changes patients attribute simply to getting older. NF-kB signaling and cytokines such as IL-6 and TNF-alpha are the primary mediators here.
Hormonal and metabolic signals do not just act in the moment, they influence which genes get transcribed, through mechanisms like DNA methylation and histone modification. This is genuinely how signals translate into sustained cellular behavior. It is also, honestly, the layer most prone to overstatement in this industry, more on that below.
Autophagy is the cell's quality-control system, clearing damaged proteins and organelles. Senescent cells, sometimes called zombie cells, stop dividing but do not die, and they secrete inflammatory signals (the senescence-associated secretory phenotype, or SASP) that affect surrounding tissue. Whether a given intervention meaningfully clears senescent cells in a person, and whether doing so translates into improved clinical outcomes, are both still being worked out in the literature, two separate questions that have not been fully answered yet.
Everything above aggregates here: muscle protein synthesis and lean mass, vascular endothelial function, neuronal and cognitive function, immune organ function. This is where cellular-level changes become physiological changes.
What the patient actually experiences, and what we can actually measure: energy, cognition, body composition, libido, recovery, immune resilience, and how someone ages. Every intervention on this site is ultimately trying to move something at this level, by way of everything above it.
What Is Redox Biology?
Every cell in your body is constantly transferring electrons as it converts nutrients and oxygen into energy. These oxidation-reduction reactions, shortened to "redox," are fundamental to life. Redox biology isn't simply about antioxidants fighting free radicals. Cells intentionally produce reactive oxygen species as signaling molecules. In appropriate amounts, these signals help regulate metabolism, adaptation, repair, immune function, and the response to exercise.
Problems can develop when oxidative stress becomes excessive or persistent and the cell can no longer appropriately regulate these signals. Mitochondrial function may decline, inflammatory signaling can increase, and cells may become less resilient. This is why redox biology is an important part of Cellular Medicine. The goal isn't to eliminate oxidative stress. It is to support the cell's ability to appropriately respond, adapt, repair, and remain resilient.
Why Your Labs Can Look Normal While You Still Feel Off
A standard reference range is a population statistic, the middle band of whoever happened to get tested for that lab, not a curated group of people functioning at their best. For a lab like total testosterone, that testing population skews older, heavier, and more often already symptomatic than a healthy young adult would be. "Normal" tells you where a value falls inside that population. It does not tell you where a specific patient functions best, and those are frequently not the same number.
This is exactly why Level 9 of the framework above, Clinical Phenotype, is defined as what the patient actually experiences and what we can actually measure, not a level-1 lab value taken in isolation. A result that clears the population reference range can still leave an individual patient short of their own physiological baseline, particularly for hormones where the reference range is wide and was never built to represent optimal function in the first place.
A 2026 retrospective cohort study in the Journal of Sexual Medicine (Hernandez et al.) illustrates this concretely. It followed 279 women already established on standard transdermal estrogen therapy, meaning their conventional labs and dosing already looked appropriate by guideline standards, who remained symptomatic until testosterone was added. Fifteen of twenty-four measured symptoms improved significantly afterward. The study has real limitations worth stating plainly: it had no control group, the symptom instrument was a modified, non-validated scale, some participants had other hormone doses adjusted at the same time, dosing was not individualized to resulting serum levels, and the cohort likely skewed toward more symptomatic women than the general population. It is a promising early signal, not settled proof, but it is a current, peer-reviewed example of the same pattern this section describes: conventionally adequate therapy that still left the Level 9 clinical picture unresolved.
None of this means labs get ignored. It means labs are one input into that Level 9 picture rather than the whole answer by themselves. The clinical approach on this site is that symptoms drive dosing over labs alone, using lab values to guide safety and direction while treating the patient's actual experience, energy, cognition, body composition, libido, recovery, as the target the framework above is ultimately built to move.
Hormones and Peptides Are Tools Inside This Framework, Not Categories Beside It
This is worth stating plainly because it is easy to get backwards. Testosterone, estradiol, and thyroid hormone are not a different subject from cellular medicine, they are cell-signaling interventions evaluated by the same framework above: what receptor they act on, what metabolic and mitochondrial effects follow, and what that produces clinically. The same is true of peptides. Every guide in the Knowledge Center includes a short note tying that specific hormone or peptide back to this framework, so you can see not just what it does, but the mechanistic chain behind why.
Mechanism Is Not the Same Thing as Proof
Understanding a mechanism and having clinical trial evidence that an intervention changes outcomes are two different things, and this framework does not blur them. Some of what is described above is extremely well established human physiology, androgen and estrogen receptor signaling, the basics of oxidative phosphorylation, insulin signaling. Other parts, particularly some of the specific claims made about autophagy, senescence, and epigenetic regulation in the context of a given hormone or peptide, rest more heavily on preclinical, cell-culture, or animal data.
Where that is the case, we say so directly rather than letting mechanism imply more than it has earned. You will see language across this site like promising in preclinical data, with clinical outcome data pending large-scale trials to confirm. That is not a discount, it means we are optimistic based on the early biology and are being straightforward about the fact that the confirming human trials have not been completed yet. Every compound guide in the Knowledge Center is written to that same standard.
Two Conditions Where This Framework Guides a Full Protocol
Most guides in the Knowledge Center apply this framework to a single hormone or peptide. These two apply it to a full clinical picture, where the diagnosis itself depends on tracking several of the levels above in sequence.
Mold Illness and CIRS
Why symptoms outlast the exposure, how the diagnosis is confirmed, and why treatment has to follow a specific, biomarker-gated sequence.
Read the Guide Inflammation & Immune RegulationLow-Dose Naltrexone (LDN)
The evidence for LDN as an immune modulator, broken down condition by condition rather than treated as one blanket answer.
Read the GuideEvery Guide Below Is Written Through This Lens
Hormones, Women's Health, Men's Health, Peptides, and Metabolic Health, five practical categories, one shared framework underneath all of them.
Have a Question, or Want to Find a Clinic?
If you're already a patient, bring this up with your care team at your next visit. If you're not a patient yet and want to ask a question first, or find one of our clinics, reach out directly.